Cytosorbents Crp (CTSO) Stock Analysis

Cytosorbents Crp (CTSO) is a publicly traded company in the HEALTHCARE sector. It trades at $0.48, carries a market capitalization of $29.38M. This page summarizes the public market data, fundamentals, and frequently asked questions for CTSO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $0.48
• Market Cap: $29.38M
• EPS: $-0.19
• 52-Week High: $1.39
• 52-Week Low: $0.43

Market Sentiment

Cytosorbents Crp currently has a Bullish sentiment score of 0.15.

About Cytosorbents Crp

Cytosorbents Corporation (CTSO) is at the forefront of critical care immunotherapy, pioneering advanced blood purification technologies to enhance patient outcomes in severe illnesses. Utilizing its proprietary adsorbent and porous polymer technology, the company effectively removes harmful substances from the bloodstream, addressing unmet medical needs in critical care. Headquartered in Monmouth Junction, New Jersey, Cytosorbents is strategically positioned to transform treatment options for...

GNG Research Analysis

GNG Research scores Cytosorbents Crp (CTSO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CTSO.

Frequently Asked Questions

Does CTSO pay dividends?

Cytosorbents Crp (CTSO) does not currently pay a regular dividend.

What is CTSO's market cap?

Cytosorbents Crp (CTSO) has a market capitalization of $29.38M with a current stock price of $0.48.